AKT1 and breast cancer: One of the candidate oncogenic mechanism of HER2 independently of PI3K/AKT and MAPK is proteolytic cleavage of HER2 and production of p95HER2 fragments which is reported correlated with more aggressiveness and poor prognosis of breast cancer.